Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: Its role in extracellular matrix formation and tumor metastasis

Journal of Experimental Medicine

Volumn 195, Issue 11, 2002, Pages 1397-1406

  Wang, Helen Y ^a   Zhou, Juhua ^a   Zhu, Kuichun ^a   Riker, Adam I ^b   Marincola, Francesco M ^c   Wang, Rong Fu ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antitumor immunity; Cancer biology; Cancer vaccines; CD4+ T cells; Immunotherapy

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; FIBRONECTIN; HLA DR2 ANTIGEN; TUMOR ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CELL MIGRATION; DNA SEQUENCE; EXTRACELLULAR MATRIX; GENE MUTATION; HUMAN; HUMAN CELL; METASTASIS; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE; TUMOR CELL;

ANTIGENS, NEOPLASM; BASE SEQUENCE; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; EXTRACELLULAR MATRIX; FIBRONECTINS; HLA-DR2 ANTIGEN; HUMANS; MELANOMA; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM METASTASIS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0037013827     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020141     Document Type: Article

References (40)

1. Tumor antigens recognized by T lymphocytes
2. Human tumor antigens for cancer vaccine development
3. Immunity against cancer: Lessons learned from melanoma
4. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma
5. A mutated betacatenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
6. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma
7. Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen
8. + T cells
9. + T cells
10. Genomic analysis of metastasis reveals an essential role for RhoC
11. A large glycoprotein lost from the surfaces of transformed cells
12. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells
13. Suppression of transformed phenotypes of human fibrosarcoma cells by overexpression of recombinant fibronectin
14. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
15. A breast and melanoma-shared tumor antigen: T cell responses to antigenic peptides translated from different open reading frames
16. Isolation and characterization of cDNA clones for human and bovine fibronectins
17. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA
18. The fibronectin receptor is organized by extracellular matrix fibronectin: Implications for oncogenic transformation and for cell recognition of fibronectin matrices
19. The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity
20. CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA-DP4 allele: Association with NY-ESO-1 antibody production
21. Reactivity of autologous CD4+ T lymphocytes against human melanoma. Evidence for a shared melanoma antigen presented by HLA-DR15
22. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin
23. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry
24. Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
25. CD4+ T cells from peripheral blood of a melanoma patient recognize peptides derived from nonmutated tyrosinase
26. + T lymphocytes
27. + cytotoxic T cells in association with histocompatibility leukocyte antigen DR11
28. Melan-A/MART-1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells
29. + T lymphocytes of patients with NY-ESO-1-expressing melanoma
30. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules
31. Identification of a MHC class II-restricted human gp100 epitope using DR4-IE transgenic mice
32. + T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes
33. A unique tumor antigen produced by a single amino acid substitution
34. The immunoprotective MHC II epitope of a chemically induced tumor harbors a unique mutation in a ribosomal protein
35. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
36. CD4 T Cells and their role in antitumor immune responses
37. CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma
38. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses
39. + T cells in the antitumor immune response
40. + T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice